SAN ANTONIO, Dec. 10, 2024 /PRNewswire/ -- The START Center for Cancer ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.
News
- The START Center for Cancer Research Expands its Capabilities to Support Early-Phase ...
- Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer ...
... San Antonio Breast Cancer Symposium, held December 10-13 in San Antonio ... Monte Rosa Therapeutics is a clinical-stage biotechnology company ...
- Houston Medicine Magazine Headlines Powered By Business Wire
Health | Biotechnology | Pharmaceutical ... View Press Release · BostonGene Unveils Transformative Breast Cancer Research at 2024 San Antonio Breast ...
- Houston Medicine Magazine Headlines Powered By Business Wire
Health | Biotechnology | Pharmaceutical ... Tempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium.
- Arvinas Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial ...
... San Antonio Breast Cancer Symposium (“SABCS”) in San Antonio, Texas on ... $ARVN. Biotechnology: Pharmaceutical Preparations. Health Care. Medical/ ...